Related references
Note: Only part of the references are listed.Resveratrol Ameliorates Diabetes-Induced Cardiac Dysfunction Through AT1R-ERK/p38 MAPK Signaling Pathway
Yonglin Gao et al.
CARDIOVASCULAR TOXICOLOGY (2016)
Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice
Han Wu et al.
BMC CARDIOVASCULAR DISORDERS (2016)
Diabetes-Induced Oxidative Stress in Endothelial Progenitor Cells May Be Sustained by a Positive Feedback Loop Involving High Mobility Group Box-1
Han Wu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS/TLR-4 signaling pathway
Zhong-wei Liu et al.
ACTA PHARMACOLOGICA SINICA (2015)
Update of mortality attributable to diabetes for the IDF Diabetes Atlas: Estimates for the year 2013
DIABETES RESEARCH AND CLINICAL PRACTICE (2015)
Dioscin ameliorates cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via HMGB-1 inhibition
Xufeng Tao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Necrotic Myocardial Cells Release Damage-Associated Molecular Patterns That Provoke Fibroblast Activation In Vitro and Trigger Myocardial Inflammation and Fibrosis In Vivo
Weili Zhang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Chronic resveratrol administration improves diabetic cardiomyopathy in part by reducing oxidative stress
Majid Mohammadshahi et al.
CARDIOLOGY JOURNAL (2014)
High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy
Antoinette Bugyei-Twum et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells
Ying Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Inhibition of high-mobility group box 1 improvesmyocardial fibrosis and dysfunction in diabetic cardiomyopathy
Wen-ke Wang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Calcitriol modulates receptor for advanced glycation end products (RAGE) in diabetic hearts
Ting-Wei Lee et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Up-regulated HMGB1 in EAM directly led to collagen deposition by a PKCβ/Erk1/2-dependent pathway: cardiac fibroblast/myofibroblast might be another source of HMGB1
Zhaoliang Su et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Impairments in mitochondrial palmitoyl-CoA respiratory kinetics that precede development of diabetic cardiomyopathy are prevented by resveratrol in ZDF rats
Marie-Soleil Beaudoin et al.
JOURNAL OF PHYSIOLOGY-LONDON (2014)
HMGB1 in health and disease
Rui Kang et al.
MOLECULAR ASPECTS OF MEDICINE (2014)
The Role of TLR2 and 4-Mediated Inflammatory Pathways in Endothelial Cells Exposed to High Glucose
Harshini Mudaliar et al.
PLOS ONE (2014)
Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE-/- mice by downregulating the HMGB1-RAGE axis
Ming Liu et al.
ACTA PHARMACOLOGICA SINICA (2013)
TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol
Peter B. Jakus et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
Cerebroprotective effect of resveratrol through antioxidant and anti-inflammatory effects in diabetic rats
Orsu Prabhakar
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2013)
Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy
Mohanraj Rajesh et al.
DIABETES (2012)
Protective effects of curcumin against hepatic fibrosis induced by carbon tetrachloride: Modulation of high-mobility group box 1, Toll-like receptor 4 and 2 expression
Chuan-tao Tu et al.
FOOD AND CHEMICAL TOXICOLOGY (2012)
Quercetin Treatment Ameliorates Inflammation and Fibrosis in Mice with Nonalcoholic Steatohepatitis
Eder Marcolin et al.
JOURNAL OF NUTRITION (2012)
Resveratrol Treatment Reduces Cardiac Progenitor Cell Dysfunction and Prevents Morpho-Functional Ventricular Remodeling in Type-1 Diabetic Rats
Francesca Delucchi et al.
PLOS ONE (2012)
HMGB1 in renal ischemic injury
May M. Rabadi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
The Role of High-Mobility Group Box-1 Protein in the Development of Diabetic Nephropathy
Junghyun Kim et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications
Ravichandran Ramasamy et al.
YEAR IN DIABETES AND OBESITY (2011)
Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure
Ling Jie Wang et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
A Resveratrol and Polyphenol Preparation Suppresses Oxidative and Inflammatory Stress Response to a High-Fat, High-Carbohydrate Meal
Husam Ghanim et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Potential Role of Nuclear Factor kappa B in Diabetic Cardiomyopathy
O. Lorenzo et al.
MEDIATORS OF INFLAMMATION (2011)
NIASPAN REDUCES HIGH-MOBILITY GROUP BOX 1/RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS AFTER STROKE IN TYPE-1 DIABETIC RATS
X. Ye et al.
NEUROSCIENCE (2011)
Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging
Hanrui Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy
M. Sulaiman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
HMGB1: the missing link between diabetes mellitus and heart failure
H. Christian Volz et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Targeting HMGB1 in inflammation
Huan Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
Dachun Yao et al.
DIABETES (2010)
Resveratrol Inhibits Neuronal Apoptosis and Elevated Ca2+/Calmodulin-Dependent Protein Kinase II Activity in Diabetic Mouse Retina
Young-Hee Kim et al.
DIABETES (2010)
Resveratrol ameliorates vasculopathy in STZ-induced diabetic rats: role of AGE-RAGE signalling
Yu-Hong Jing et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2010)
The Role of HMGB1/RAGE in Inflammatory Cardiomyopathy
Hans C. Volz et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of Toll-like receptor-4
Yuwei Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
High-mobility group box-1 in ischemia-reperfusion injury of the heart
Martin Andrassy et al.
CIRCULATION (2008)
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes
Aino Soro-Paavonen et al.
DIABETES (2008)
The role of the receptor for advanced glycation end-products in lung fibrosis
Mei He et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Diabetic cardiomyopathy revisited
Sihem Boudina et al.
CIRCULATION (2007)
Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: Role of HMGB1-TLR4 signaling
Jie Fan et al.
JOURNAL OF IMMUNOLOGY (2007)
Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1
Daolin Tang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
Goodarz Danaei et al.
LANCET (2006)
Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: Molecular targets are TBK1 and RIP1 in TRIF complex
HS Youn et al.
JOURNAL OF IMMUNOLOGY (2005)
Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms
GQ Chen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)